Big Molecule Watch
- Insulin Updates: March 2023 March 22, 2023 Beth Ashbridge
- Janssen Files Redacted Public Version of Its Opening Brief in Support of Its Motion for Preliminary Injunction Against Amgen in BPCIA Ustekinumab Case March 22, 2023 Emily Rapalino
- Aflibercept IPRs Update March 15, 2023 Joshua Weinger
- Coherus Biosciences Announces Approval of a Pegfilgrastim Autoinjector March 14, 2023 Maria C. Smith|Stephanie Dusaban Gonzales
- Biogen Launches BYOOVIZ (ranibizumab) in Canada March 10, 2023 Lihui Bai
- Women’s History Month Spotlight: Brigitte Askonas March 9, 2023 Huiya Wu
- Janssen Seeks a Preliminary Injunction in BPCIA Ustekinumab Case Against Amgen March 8, 2023 Harrison Gunn
- Alkem Subsidiary Enzene Launches Adalimumab Biosimilar in India March 3, 2023 Kristin Beale
- Genentech Files Lawsuits Against Biogen and Millennium for Past Royalties on the Cabilly Patents March 3, 2023 Kevin DeJong
- USPTO Extends Deadline for Comments on USPTO-FDA Collaboration Initiatives March 1, 2023 Zachariah Holmes
BioPharma Reporter
- BioNTech and OncoC4 team up on novel checkpoint antibody March 21, 2023
- Vaccitech reports positive interim data in study on immunotherapeutic for HPV infection March 21, 2023
- Novartis and Biogen exit deals with Sangamo March 21, 2023
- Orgenesis and UC Davis partner on decentralized development and manufacturing of CGTs March 20, 2023
- Vaxart reduces workforce and pauses COVID-19 vaccine development March 20, 2023
- Novartis releases long-term Zolgensma data March 20, 2023
- Samsung Biologics to start construction of Plant 5 March 20, 2023
- Teknova and Sartorius look to address critical pain points in AAV bioprocessing March 20, 2023
- MHRA gets £10m boost from UK government March 16, 2023
- Genuv and Celltrion partner on antibody discovery work March 16, 2023